-
SFDA Commissioner Yin Li meets the Ambassador of Switzerland to ChinaOn the afternoon of February 4, 2013, Yin Li, Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Mr. Jacques de Watteville, the Ambassador of Switzerland to China, an2013/2/17
-
Merck loses 'bellwether' Fosamax caseYou win some and you lose some and this time, Merck ($MRK) lost to the tune of $285,000 when a jury said it was not up front about the risks of osteoporosis drugFosamax. And the sting of this loss was2013/2/7
-
GSK to hack jobs in Europe where austerity has taken tollEuropean austerity is taking on a very personal meaning at GlaxoSmithKline ($GSK).CEO Sir Andrew Wittysays more cost-cutting is coming, and the brunt of it will fall on workers and operations in Europ2013/2/7
-
Lallemand inaugurates its newest division - “Lallemand Health Solutions”Montreal, Canada... Lallemand Inc is pleased to announce the birth of its new division ‘’Lallemand Health Solutions’’. This new entity consolidates the internationally recognized probiotic manufacture2013/2/6
-
While BMS shops emerging markets brands, GSK wraps $900M buy in IndiaTwo consumer health deals, two Big Pharma approaches toward emerging markets. While Bristol-Myers Squibb ($BMY) is looking around for buyers for a portfolio of consumer brands in Latin America, GlaxoS2013/2/6
-
SFDA issues notice on implementation of electronic supervision of imported drugsTo implement the 2011-2015 Work Plan for Electronic Supervision of Drugs and other related work requirements, the State Food and Drug Administration (SFDA) recently issued a notice on implementation o2013/2/5
-
FDA approves generic Doxil to combat drug shortageIt can pay to play with the FDA when it needs help with drug shortages. In a push to ease a months-long shortage of Johnson & Johnson's($JNJ)cancer drugDoxil, the FDA fast-tracked a generic fromSu2013/2/5
-
Exports to U.S. to power Indian drugmaker growthThe market forIndiandrugmakers is looking good. Growth this year could reach 20% as exports to the U.S. are driving sales, a report from India Ratings says. "Of the export markets, Indian pharma will2013/2/4
-
U.S. finally gets payment rule publishedIt is 15 months overdue and it will be more than a year before information is public, but at last the government has set out its rule for how it will publishpaymentsfrom drugmakers to doctors. Drug a2013/2/4
-
Merck has to trim outlook as pipeline poops outMerckCEOKenneth Fraziertoday had to give shareholders the bad news and then he had to follow that up with the really bad news. Profit fell 7.3% in the fourth quarter as generics ate the lunch of its2013/2/1